Catching up on my October 5 buy of Twilio
This is something of a catch up post. On October 5 I added Twilio (TWLO) to my Jubak Picks and Volatility portfolios. I announced that buy in a post on October 2 and then again in my Special Report: “Your Investing Guide for the Next 6 Dangerous Stock Market...
Twilio jumps 13% today on increase in company estimates of sale growth
Twilio (TWLO), which makes cloud-based software, climbed 13% today after analysts raised price-target after Thursday’s investors day event. (For example Morgan Stanley raised its price garget for Twilio to $270 from $240. I would note the stock closed at $290...
Adding Illumina to Jubak Picks on today’s pullback
Shares of Illumina (ILMN) dropped 8.44% today, September 16, on reports by both Reuters and Bloomberg that the genetic sequencing marketing leader is in talks to acquire Grail, a still private startup focused on blood tests for the early detection of cancer. I think...
Selling Agenus and Amyris out of my portfolios
Just want to make sure that everyone caught this sell decision that I made first on my subscription JubakAM.com website. I’m selling Agenus (AGEN) and Amyris (AMRS) out of both my Jubak Picks and Volatility portfolios. I added both stocks to these portfolios on...
Adding West Pharmaceutical Services to Jubak Picks Portfolio on rotation back to momentum winners
What a difference 72 hours can make. Just a few days ago I was looking to find consumer/cyclical/”re-opening dependent” shares as the stock market looked to be rotating away from recent technology and momentum leaders and toward beaten down shares that...
Incyte beats on earnings, revenue–but drops on lack of improved guidance
Shares of biotech Incyte (INCY) were down 2.60% as of 1:30 p.m. Tuesday on earnings and revenue that stomped Wall Street projections. The company reported second quarter adjusted earnings of $1.24 a share versus Wall Street projections for 50 cents a share. Earnings...
Ericsson is my 5G network pick
Ericsson (ERIC) has been piling up the contract wins for 5G networks. That’s the future–which is why I’m recommending buying this ADR in my Jubak Picks Portfolio today. If you want to ride the transition to 5G telecommunications network, this is the...
Microsoft’s growth disappoints Wall Street in yesterday’s earnings report
Shares of Microsoft (MSFT) were down 4.35% as of the close today in spite of the company’s strong beat of Wall Street projections for the company’s fiscal fourth quarter that ended on June 30. The company reported earnings of $1.46 a share, versus Wall...
Jubak Picks member Xylem gains 8.97% on upgraded guidance ahead of earnings
Just a reminder today from Xylem (XYL) of why the company is one of the best investments in trends in the water market. The shares moved up 8.97% ahead of the release of second quarter earnings on July 30, 2020 to close at $73.38. Today, July 14, I’m raising my...
Selling Salesforce out of my Jubak Picks Portfolio as shares hit target price
Salesforce (CRM) has hit my $185 a share target price. I’m selling it out of my Jubak Picks Portfolio with a 37.42% gain since I added that position back on November 1, 2018. Why sell rather than up the target price? A couple of four reasons for what amounts to...
Selling Japanese yen ETF out of Jubak Picks Portfolio
A while back I sold the Invesco Currency Shares Japanese Yen ETF (FXY) out of my Perfect Five ETF Portfolio because I was looking for more diversification in that limited five ETF portfolio. (I replaced it with the iShares Large Cap China ETF (FXI) on April 20, 2020....
Jubak Picks member Visa to benefit from post-corona trends
Visa’s ads remind up that the credit card is everywhere you want to be. But that’s actually not true when it comes to payments below $10. In the United States 55% of payments below $10 are still in cash. Visa has targeted that as a huge opportunity for...
My Stock Pick of the Day: Xylem (XYL)
Xylem (XYL) is that rare coin on raw market–a pure play water stock at a time when foresighted investors are looking for water stocks and realizing how few of them exist. (The basic water story is that Mother Nature isn’t making more of it. Rising global...
Stock Pick of the Day: Barrick Gold (GOLD)
I can think of two reasons to buy shares of Barrick Gold (GOLD) now. Either one alone would be enough to justify a “buy.” First, sentiment is shifting among investors toward the idea of buying gold as protraction against currency depreciation. The U.S....
Selling Restaurant Brands into today’s “another coronavirus rescue bill” bounce
There was that little detour for the complete and utter meltdown in the oil market, but now I’m resuming my plan to sell into the “re-opening the economy rally.” That rally is in its last stages I believe, with its life extended by another...
Selling infrastructure play United Rentals out of Jubak Picks into today’s rally
This sell follows the same logic as my immediately prior sell of Vulcan Materials. Last week House Speaker Nancy Pelosi threw in the towel on any near-term chance for a big infrastructure spending package. The horrific jobs numbers had convinced her, she said, that...
Good news out of Palo Alto Networks doesn’t count for much in a bear market–but enough to earn a hold from me
The problem isn’t that there’s no good news out of individual companies. It’s just that good news on specific stocks doesn’t count for much in a bear market when everything moves together in a single direction–most usually down. Take Palo...
Selling GM out of the Jubak Picks Portfolio today
Automakers are scheduled to report first quarter sales numbers tomorrow with Ford Motor (F), Fiat Chrysler, and General Motors (GM) all expected to snow big declines. And the next quarter looks even worse. “There are basically no U.S. auto sales right now,” Adam...
Danaher unit gets FDA approval for fast coronavirus test
Late Friday night, the U.S. Food And Drug Administration gave emergency approval to Cepheid’s Xpert Xpress test for coronavirus. The test is the first that can be conducted entirely at point of care for a patient–at a hospital, for instance–without...
SolarEdge rockets 17.94% today on analyst upgrades ahead of earnings today after the close
SolarEdge Technologies (SEDG) closed up 17.94% today ahead of fourth quarter earnings due after the close. Cascend Securities raised its target price on the shares by 17% during today’s session. Today’s jump will, of course, make it harder for the company...
Raising target on Barrick Gold in Jubak Picks Portfolio and buying the shares for my Dividend Portfolio
Barrick Gold (GOLD) reported fourth quarter earnings of 17 cents a share on Wednesday, February 12. That beat the 14 cents a share estimate from Wall Street analysts for the quarter. A year ago the company earned 6 cents a share in the fourth quarter of 2018. But that...
Adding Bargain Pick #11 Wesco International to Jubak Picks
Last night, I made Wesco International (WCC) my #11 Pick for my Special Report: 12 Bargain Stock Picks NOW on my Jubak.com subscription site. Today I’m adding Wesco International to my Jubak Picks Portfolio. As the market continues to climb to new records,...
FDA and Nektar both shock on company’s opioid drug candidate; I’d buy more on weakness
Yesterday an advisory joint committee at the U.S. Food & Drug Administration voted to reject Nektar’s application for its new non-addictive opioid NKTR-181. The thinking–my thinking–was that the committee had structured the vote so that the most...
Nektar’s new non-addictive opioid NKTR-181 to finally get an FDA advisory vote tomorrow
I understand why the U.S. Food & Drug Administration has moved so slowly on a decision on Nektar Therapeutic’s (NKTR) new non-addictive opioid NKTR-181. The last thing the FDA wants to do in the midst of epidemic of opioid addiction is to approve a drug...
Norway’s Equinor oil company invests in Bill Gates’ cobalt mapping startup
Norwegian oil company Equinor (EQNR) has decided to take a 10% stake in start-up Kobold Metals. Kobold’s aim is to apply artificial intelligence to big subsurface data to create what it calls a “Google Maps” of the Earth’s crust that will...
Danaher and Nvidia get European Union approval for big acquisitions
Looking at the history of intense scrutiny and strict conditions for winning approval, no U.S. technology company can take approval from European Union regulators on a big deal for granted. That’s why the news from regulators on acquisitions planned by Danaher...
Here’s how to think about Danaher’s offer to exchange shares for the Envista spin off
Danaher (DHR) has announced an exchange offer for shares of Envista Holdings (NVST), the dental services and supplies company recent spun off from Danaher. After Envista’s September IPO Danaher still held 80.6% of Envista shares. The exchange offer would allow...
Lionsgate UK deal with Amazon raises speculation on a U.S. deal for studio’s content
Amazon (AMZN) and Lionsgate (LGF/A) have struck a deal that will put Lionsgate’s newest releases on Amazon’s streaming platform. The multiyear deal that begins on January 1, 2020, will give Amazon subscribers access to current box-office star Knives Out...
Selling Synaptics out of my Jubak Picks portfolio tomorrow
When Synaptics (SYNA) traded at $40 I though the shares were undervalued. At $60 I think they’re close to full value. My target price on the stock is $64 and the shares closed at $58.51 today, up 2.94% on the day. Tomorrow I’m going to take advantage of...Jim’s Daily Email Alerts:
Every post from Jubak Picks straight to your mailbox. And they're free!